BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15377638)

  • 1. Loss of FMR1 hypermethylation in somatic cell heterokaryons.
    Stoyanova V; Rossetti S; VAN Unen L; Oostra BA; Hoogeveen AT
    FASEB J; 2004 Dec; 18(15):1964-6. PubMed ID: 15377638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intragenic loss of function mutations demonstrate the primary role of FMR1 in fragile X syndrome.
    Lugenbeel KA; Peier AM; Carson NL; Chudley AE; Nelson DL
    Nat Genet; 1995 Aug; 10(4):483-5. PubMed ID: 7670500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Methylation and expression of the FMR1 gene].
    Pintado E; Morón FJ
    Rev Neurol; 2001 Oct; 33 Suppl 1():S57-62. PubMed ID: 12447821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A methylation PCR approach for detection of fragile X syndrome.
    Panagopoulos I; Lassen C; Kristoffersson U; Aman P
    Hum Mutat; 1999; 14(1):71-9. PubMed ID: 10447261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rare variants in the promoter of the fragile X syndrome gene (FMR1).
    Milà M; Castellví-Bel S; Sánchez A; Barceló A; Badenas C; Mallolas J; Estivill X
    Mol Cell Probes; 2000 Apr; 14(2):115-9. PubMed ID: 10799273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A fragile gene.
    Oostra BA; Willems PJ
    Bioessays; 1995 Nov; 17(11):941-7. PubMed ID: 8526888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation mosaicism of 5'-(CGG)(n)-3' repeats in fragile X, premutation and normal individuals.
    Genç B; Müller-Hartmann H; Zeschnigk M; Deissler H; Schmitz B; Majewski F; von Gontard A; Doerfler W
    Nucleic Acids Res; 2000 May; 28(10):2141-52. PubMed ID: 10773084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular-intelligence correlations in young fragile X males with a mild CGG repeat expansion in the FMR1 gene.
    Steyaert J; Borghgraef M; Legius E; Fryns JP
    Am J Med Genet; 1996 Aug; 64(2):274-7. PubMed ID: 8844064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of the FMR1 gene mutation to human intellectual dysfunction.
    Reiss AL; Freund LS; Baumgardner TL; Abrams MT; Denckla MB
    Nat Genet; 1995 Nov; 11(3):331-4. PubMed ID: 7581460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redistribution of transcription start sites within the FMR1 promoter region with expansion of the downstream CGG-repeat element.
    Beilina A; Tassone F; Schwartz PH; Sahota P; Hagerman PJ
    Hum Mol Genet; 2004 Mar; 13(5):543-9. PubMed ID: 14722156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Methylation status of the FMR1 gene promotor in patients with Martin-Bell syndrome from Ukraine].
    Grishchenko NV; Maliarchuk SG; Ekshiian AIu; Bychkova AM; Livshits LA
    Tsitol Genet; 2002; 36(4):53-6. PubMed ID: 12379018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion in the FMR1 gene in a fragile-X male.
    Mannermaa A; Pulkkinen L; Kajanoja E; Ryynänen M; Saarikoski S
    Am J Med Genet; 1996 Aug; 64(2):293-5. PubMed ID: 8844068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative analysis of DNA demethylation and transcriptional reactivation of the FMR1 gene in fragile X cells treated with 5-azadeoxycytidine.
    Pietrobono R; Pomponi MG; Tabolacci E; Oostra B; Chiurazzi P; Neri G
    Nucleic Acids Res; 2002 Jul; 30(14):3278-85. PubMed ID: 12136110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mosaicism in a fragile X male including a de novo deletion in the FMR1 gene.
    Petek E; Kroisel PM; Schuster M; Zierler H; Wagner K
    Am J Med Genet; 1999 May; 84(3):229-32. PubMed ID: 10331598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An assay for X inactivation based on differential methylation at the fragile X locus, FMR1.
    Carrel L; Willard HF
    Am J Med Genet; 1996 Jul; 64(1):27-30. PubMed ID: 8826444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced FMR1 mRNA translation efficiency in fragile X patients with premutations.
    Primerano B; Tassone F; Hagerman RJ; Hagerman P; Amaldi F; Bagni C
    RNA; 2002 Dec; 8(12):1482-8. PubMed ID: 12515381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fragile X syndrome and deletions in FMR1: new case and review of the literature.
    Hammond LS; Macias MM; Tarleton JC; Shashidhar Pai G
    Am J Med Genet; 1997 Nov; 72(4):430-4. PubMed ID: 9375726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular-clinical correlations in males with an expanded FMR1 mutation.
    Merenstein SA; Sobesky WE; Taylor AK; Riddle JE; Tran HX; Hagerman RJ
    Am J Med Genet; 1996 Aug; 64(2):388-94. PubMed ID: 8844089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fmr1 knockout mice: a model to study fragile X mental retardation. The Dutch-Belgian Fragile X Consortium.
    Cell; 1994 Jul; 78(1):23-33. PubMed ID: 8033209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fragile X phenotype in a mosaic male with a deletion showing expression of the FMR1 protein in 28% of the cells.
    de Graaff E; de Vries BB; Willemsen R; van Hemel JO; Mohkamsing S; Oostra BA; van den Ouweland AM
    Am J Med Genet; 1996 Aug; 64(2):302-8. PubMed ID: 8844070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.